The Neuropathology Core C will provide neuropathologic diagnostic service for all program project subjects who come to autopsy. The CERAD neuropathology protocol will be used to assess general neuropathogic findings. The NIA/AARP quantitative diagnostic criteria will be used to establish a pathologic diagnosis of Alzheimer's disease (AD). The Core will use quantitative manual and automated computer-assisted morphometric methods to determine patterns, prevalence and severity of neuron atrophy and loss and NP and NFT accumulation associated with aging, AD, and AD-associated with Parkinsonism. Multivariate statistics will be used to correlate pathologic lesions with clinical and psychometric measures, especially important in mild dementia. The Core will process an estimated 25 brains annually. We will provide neuropathologic documentation of specific lesions and diseases in our aging and demented and nondemented aged samples. WE will provide the data for validation of clinical diagnostic criteria for subjects in Project 1 (intellectual function and Alzheimer changes in the very old), Project 3 (SDAT and Parkinsonism), Project 4 (memory processing in aging and dementia), Project 5 (lay interviewer assessment), Project 7 (neuroanatomical markers), and Project 8 (PET in aging and SDAT). Histologic criteria for differentiation of healthy aging and AD in the very old will be clarified. The neuropathological basis of parkinsonism in AD will be clarified. The hypothesis that parkinsonian dementia is due to SDAT-like neuropathology will be tested. By studying cases of mild SDAT and counting neuritic plaques by subtypes, we will test the additional hypothesis that purely fibrillary plaques are precursors to classical plaques with expanded neurites and amyloid cores. Our studies will identify how hippocampal, basal forebrain and neocorticallesions are related to dementia in AD. The relevant material for this effort includes those healthy control subjects enrolled in the Clinical Core who come to autopsy in the stages of very mild dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG003991-09
Application #
3090780
Study Section
Aging Review Committee (AGE)
Project Start
1984-01-01
Project End
1993-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
9
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Aschenbrenner, Andrew J; Gordon, Brian A; Benzinger, Tammie L S et al. (2018) Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology 91:e859-e866
Day, Gregory S; Musiek, Erik S; Morris, John C (2018) Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions. Alzheimer Dis Assoc Disord 32:291-297
Karch, Celeste M; Hernández, Damián; Wang, Jen-Chyong et al. (2018) Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network. Alzheimers Res Ther 10:69
Villeneuve, Sylvia; Vogel, Jacob W; Gonneaud, Julie et al. (2018) Proximity to Parental Symptom Onset and Amyloid-? Burden in Sporadic Alzheimer Disease. JAMA Neurol 75:608-619
Day, Gregory S; Gordon, Brian A; Perrin, Richard J et al. (2018) In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease. Neurology 90:e896-e906
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 97:1284-1298.e7
Lewczuk, Piotr; Riederer, Peter; O'Bryant, Sid E et al. (2018) Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry 19:244-328
Vardarajan, Badri N; Barral, Sandra; Jaworski, James et al. (2018) Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer's disease. Ann Clin Transl Neurol 5:406-417
Joseph-Mathurin, Nelly; Su, Yi; Blazey, Tyler M et al. (2018) Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease. Alzheimers Dement (Amst) 10:669-677
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558

Showing the most recent 10 out of 911 publications